Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/GFM813PMID 18057066
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Agalsidase-Beta Therapy for Advanced Fabry Disease

  2007cited by this paper
• Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

  2007influential reference
• Agalsidase-Beta Therapy for Advanced Fabry Disease A Randomized Trial

  2006cited by this paper
• Clinical benefit of enzyme replacement therapy in Fabry disease.

  2006cited by this paper
• Enzyme replacement therapy in Fabry disease patients undergoing dialysis: effects on quality of life and organ involvement.

  2005cited by this paper
• The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease.

  2005cited by this paper
• Enzyme replacement therapy administered during hemodialysis in patients with Fabry disease.

  2004cited by this paper
• Renoprotection by enzyme replacement therapy

  2004influential reference
• Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.

  2004cited by this paper
• Results of a nationwide screening for Anderson-Fabry disease among dialysis patients.

  2004cited by this paper
• Enzyme replacement therapy with agalsidase beta in kidney transplant patients with Fabry disease: a pilot study.

  2004cited by this paper
• Improvement of Cardiac Function During Enzyme Replacement Therapy in Patients With Fabry Disease: A Prospective Strain Rate Imaging Study

  2003cited by this paper
• Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

  2003cited by this paper
• Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.

  2003cited by this paper
• Natural history and treatment of renal involvement in Fabry disease.

  2002cited by this paper
• Enzyme replacement therapy for Fabry disease, an inherited nephropathy.

  2002cited by this paper
• Rapid quantitation of globotriaosylceramide in human plasma and urine: a potential application for monitoring enzyme replacement therapy in Anderson-Fabry disease.

  2002cited by this paper
• Patients with Fabry disease on dialysis in the United States.

  2002influential reference
• Cardiac manifestations of Anderson-Fabry disease in heterozygous females.

  2002cited by this paper
• α-Galactosidase A deficiency. Fabry disease

  2001cited by this paper
• Long-term survival of patients with renal transplantation in Fabry's disease.

  2001cited by this paper
• Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

  2001cited by this paper
• Excellent outcome of renal transplantation in patients with Fabry's disease.

  2000cited by this paper
• Clinical epidemiology of cardiovascular disease in chronic renal disease.

  1998cited by this paper
• Report on management of renale failure in Europe, XXVI, 1995. Rare diseases in renal replacement therapy in the ERA-EDTA Registry.

  1996cited by this paper
• Report on management of renal failure in Europe, XXIV, 1993.

  1995cited by this paper
• Report on management of renal failure in Europe, XXIII.

  1994cited by this paper
• Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease

  1990cited by this paper
• Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation.

  1985cited by this paper
• Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method

  1977influential reference
• Enzyme replacement therapy by renal allotransplantation in Fabry's disease.

  1972cited by this paper

• Clinical Efficacy and Real-World Effectiveness of Fabry Disease Treatments: A Systematic Literature Review

  2025cites this paper
• Adequate hemodialysis does not compromise the cardioprotective effect of agalsidase alfa on patients with Fabry disease: a case report

  2025cites this paper
• Outcomes and management of kidney transplant recipients with Fabry disease: a review

  2024cites this paper
• Fabry nephropathy: a treatable cause of chronic kidney disease

  2024cites this paper
• Precision medicine in Fabry disease.

  2021cites this paper
• Migalastat Treatment in a Kidney-Transplanted Patient with Fabry Disease and N215S Mutation: The First Case Report

  2021cites this paper
• Clinical Outcomes of People With Fabry Disease — ANZDATA Registry Study

  2021cites this paper
• Fabry disease and kidney involvement: starting from childhood to understand the future

  2021cites this paper
• Screening for Fabry Disease in Kidney Transplant Recipients: Experience of a Multidisciplinary Team

  2020cites this paper
• Outcomes of Kidney Transplantation in Fabry Disease: A Meta-Analysis

  2020cites this paper
• A late-onset male Fabry disease patient with somatic mosaicism of a classical GLA mutation: a case report.

  2020cites this paper
• Treatment of Anderson-Fabry disease.

  2020cites this paper
• Kidney Transplant in Fabry Disease: A Revision of the Literature

  2020cites this paper
• Recurrent and De Novo Renal Diseases After Kidney Transplantation

  2019cites this paper
• The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: A systematic literature review by a European panel of experts

  2019cites this paper
• In silico analysis of two novel Alpha-Galactosidase-A variants in patients with suspected Fabry disease

  2019cites this paper
• p.G360R Is a Pathogenic GLA Gene Mutation Responsible for a Classic Phenotype of Fabry Disease

  2019cites this paper
• Fabry Nephropathy: An Evidence-Based Narrative Review

  2018cites this paper
• Parapelvic cysts, a distinguishing feature of renal Fabry disease

  2018cites this paper
• Skin globotriaosylceramide 3 deposits are specific to Fabry disease with classical mutations and associated with small fibre neuropathy

  2017cites this paper
• Different renal phenotypes in related adult males with Fabry disease with the same classic genotype

  2017cites this paper
• Diagnosis and management of nephropathy in Fabry disease

  2017cites this paper
• E-Learning for Rare Diseases: An Example Using Fabry Disease

  2017cites this paper
• The management of Fabry nephropathy

  2016cites this paper
• Double-target Antisense U1snRNAs Correct Mis-splicing Due to c.639+861C>T and c.639+919G>A GLA Deep Intronic Mutations

  2016cites this paper
• Anderson ‑Fabry disease: Ten ‑year outcome of enzyme replacement therapy in a renal transplant patient

  2016cites this paper
• Fabry’s disease: an example of cardiorenal syndrome type 5

  2015cites this paper
• The kidney in Fabry's disease

  2014cites this paper
• Plasma mutant α-galactosidase A protein and globotriaosylsphingosine level in Fabry disease

  2014cites this paper
• Screening for Fabry disease: indications, methods and implications

  2013cites this paper
• Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.

  2013cites this paper
• Renal complications of Fabry disease.

  2013cites this paper
• Kidney transplantation and enzyme replacement therapy in patients with Fabry disease.

  2013cites this paper
• Терминальная хроническая почечная недостаточность: оценка риска, этапы терапии и кардиальные проблемы

  2013cites this paper
• La Enfermedad de Fabry en pacientes en hemodiálisis, valoración del tratamiento enzimático sustitutivo

  2012cites this paper
• UNGRADED SUGGESTIONS FOR CLINICAL CARE IMPLEMENTATION AND AUDIT

  2012cites this paper
• Enzyme replacement therapy in patients with Fabry disease: state of the art and review of the literature.

  2012cites this paper
• Renal Transplantation in Patient with Fabry’s Disease Maintained by Enzyme Replacement Therapy

  2012cites this paper
• The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.

  2012cites this paper
• Maladie de Fabry : une maladie du métabolisme par déficit d’une enzyme lysosomale (alpha-galactosidase), de transmission héréditaire liée au chromosome X accessible au traitement enzymatique de substitution

  2011cites this paper
• [Management of Fabry disease].

  2010cites this paper
• Effects of enzyme replacement therapy in Fabry disease—A comprehensive review of the medical literature

  2010cites this paper
• Electron Microscopy in End Stage Renal Disease: A Case of Fabry's Disease

  2010cites this paper
• Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy.

  2010cites this paper
• Effects of enzyme replacement therapy on a Fabry disease patient receiving hemodialysis: Pharmacokinetics of agalsidase alpha in a hemodialysis patient

  2010cites this paper
• Fabry disease

  2010cites this paper
• End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.

  2010cites this paper
• Fabry disease: a review of current management strategies.

  2010cites this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cites this paper
• Anderson–Fabry disease: a case‐finding study among male kidney transplant recipients in Austria

  2009cites this paper
• Deceased renal transplantation in patient with Fabry's disease maintained by enzyme replacement therapy

  2009cites this paper
• Enzyme Replacement Therapy for Fabry Disease

  2009cites this paper
• The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease

  2009cites this paper
• Anaesthesiologic protocol for kidney transplantation in two patients with Fabry Disease: a case series

  2008cites this paper
• Safety and efficacy of enzyme replacement therapy in the nephropathy of Fabry disease

  2008cites this paper